A separation and purification device for stem cell exosomes and paracrine active macromolecules and a method for using the same

By combining hollow fiber membrane filtration and low-adsorption magnetic bead affinity adsorption, the separation and purification device solves the problems of slow extraction speed and high cost of stem cell exosomes and paracrine active macromolecules in the existing technology, and realizes efficient and low-cost automated separation and purification.

CN115747049BActive Publication Date: 2024-11-26SHANDONG YIYUAN PLURIPOTENT STEM CELL BIOENGINEERING CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211330989.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-28
Publication Date
2024-11-26
Estimated Expiration
2042-10-28

AI Technical Summary

Technical Problem

Existing technologies lack efficient separation and purification devices and methods to simultaneously extract stem cell exosomes and paracrine active macromolecules, resulting in slow extraction speed, low recovery rate and high cost.

Method used

A device for separating and purifying stem cell exosomes and paracrine active macromolecules is used, which combines hollow fiber membrane filtration, low-adsorption magnetic bead affinity adsorption and automated suction technology to achieve simultaneous separation and purification of exosomes and active macromolecules.

Benefits of technology

It improves the extraction speed and recovery rate of exosomes and active macromolecules, reduces consumable costs, and enhances product quality stability through automated operation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115747049B_ABST
    Figure CN115747049B_ABST
Patent Text Reader

Abstract

The present invention discloses a separation and purification device for stem cell exosomes and paracrine active macromolecules and a method for using the same. The separation and purification device includes a main control panel device, a liquid storage device and a liquid storage rack. The main control panel device includes an ultrafiltration purification device. The ultrafiltration purification device includes a circulation pump, a hollow fiber ultrafiltration membrane fixing frame, a magnetic plate, a magnetic bead container fixing clamp, and an electric pressure regulator. The hollow fiber ultrafiltration membrane fixing frame is used to fix the hollow fiber ultrafiltration membrane, and the magnetic plate and the magnetic bead container fixing clamp are used to fix the low adsorption magnetic bead container. The present invention organically combines tangential flow microfiltration, tangential flow ultrafiltration and magnetic bead adsorption into a set of separation systems to separate and purify exosomes and active macromolecules in cell culture fluid, overcomes the shortcomings of a single method, and further strengthens the advantages of a single method, thereby improving the purity and extraction efficiency of the product.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of bioengineering technology, and specifically relates to a separation and purification device for stem cell exosomes and paracrine active macromolecules and a method for using the device. Background Art

[0002] As a popular research direction in recent years, stem cell therapy has been proven to have great clinical application value. Among them, mesenchymal stem cells are widely used in clinical research on various diseases due to their wide sources, strong regenerative ability and excellent immunoregulatory ability. At present, it is generally believed that mesenchymal stem cells play their main role through paracrine. Stem cell paracrine factor therapy, as a cell-free treatment method, greatly reduces the risks of rejection and ectopic differentiation after allogeneic transplantation. It has achieved remarkable results in research in many fields such as trauma repair, ischemic diseases, COVID-19 treatment, medical beauty, and facial plastic surgery. Stem cell paracrine factors used for treatment or medical beauty mainly include exosomes, as well as various growth factors, nutritional factors and other biomacromolecules. Although stem cell paracrine factors have shown great potential in the above research fields, their complex composition, low yield and low separation and purification efficiency have greatly limited their clinical application.

[0003] Exosomes carry important biological molecules from maternal cells, including RNA, proteins, lipids, metabolites and other molecules, and play a vital role in cell signal transduction and cell physiological and pathological activities. In recent years, it has become a research hotspot in the field of stem cell therapy, and has shown significant therapeutic effects in the treatment of many diseases. However, in cell physiological activities, there are many biological structures with similar structures but different functions, such as microvesicles (100~1000nm) and apoptotic bodies (50~4000 nm). Therefore, the identification and control of the key quality attributes of exosome products (such as size, purity, molecular composition, markers, etc.) will be the key to affecting their efficacy and stability, and it is also an important factor in determining whether they will eventually be successfully applied in clinical practice. At present, the extraction of exosomes mainly includes differential ultracentrifugation, density gradient centrifugation, ultrafiltration, polymer precipitation, and immunoaffinity separation. The separation principles are different, and the product extraction efficiency, purity, recovery rate, and extraction cost are different. The main methods for separating and purifying macromolecular active factors secreted by stem cells are ultrafiltration, dialysis and other means, which mainly achieve the purpose of desalting and decolorizing the product.

[0004] In the above methods, the ultrafiltration method is the most suitable method for large-scale production. Currently, the most widely used is the tangential flow ultrafiltration method, which can process a large amount of culture medium and has a relatively high separation efficiency. However, due to the principle limitation of particle size separation in the ultrafiltration method, there is a "extrusion effect" of particles in this method, which will cause the concentration rate of exosomes to become slower and slower, and ultimately a very high-concentration product cannot be obtained. Generally, it is necessary to further concentrate with the ultracentrifugation method, and the overall recovery rate is relatively low. The immunoaffinity separation method, a typical method is the immunomagnetic bead separation method, which is currently the most suitable method for extracting exosomes in small batches in the laboratory. Based on the specific marker proteins or membrane structure molecules on the surface of exosomes, magnetic beads are cross-linked with corresponding antibodies to directly adsorb exosomes in the culture medium, and then eluted with an eluent to obtain exosomes with very high purity, and the extraction speed is very fast. And different subtypes of exosomes can be separated by selecting different antibodies. However, the processing capacity of this method is very low, and it is necessary to mix magnetic beads and culture medium in a relatively high proportion to achieve better adsorption. And the price of magnetic beads is expensive, which is not suitable for the treatment of a large amount of culture medium.

[0005] However, there is no perfect method for the separation and purification of the macromolecular active factors secreted by stem cells. Mainly, the complete cell culture medium, especially the medium supplemented with serum or serum substitutes, also contains many biological macromolecules, which are difficult to be completely distinguished from the biological macromolecules secreted by the cells themselves. Summary of the Invention

[0006] Aiming at the problems that there is no separation and purification device for simultaneously separating stem cell exosomes and paracrine active macromolecules and the separation and extraction speed is slow in the prior art, the present invention discloses a separation and purification device for stem cell exosomes and paracrine active macromolecules and its use method, obtaining a relatively high recovery rate and a relatively fast extraction speed.

[0007] The present invention is realized through the following technical solutions:

[0008] A separation and purification device for stem cell exosomes and paracrine active macromolecules, comprising a main control panel device, a liquid storage device and a liquid storage hanger;

[0009] The main control panel device includes a touch operation screen, a pretreatment device, an ultrafiltration purification device and a suction device. The liquid storage device includes a stock solution cylinder base and a filtrate cylinder base for fixing the stock solution cylinder and the filtrate cylinder. The liquid storage hanger is in the shape of a "king", and the horizontal bars from top to bottom are the hanger horizontal bar, the hanger pipeline electric clamp horizontal bar and the hanger base respectively. The vertical rod is the hanger vertical column. A number of hooks are installed on the hanger horizontal bar for fixing the buffer solution and the eluent. A number of hanger pipeline electric clamps are installed on the hanger pipeline electric clamp horizontal bar to control the inflow of the buffer solution and the eluent. The buffer solution and the eluent are selectively connected to the filtrate cylinder pipeline;

[0010] The pretreatment device comprises a filter fixing frame and a pretreatment pump, the filter fixing frame is used to fix the hollow fiber microfiltration membrane, the raw liquid cylinder is connected to the pretreatment pump and the hollow fiber microfiltration membrane pipeline, the hollow fiber microfiltration membrane is connected to the raw liquid cylinder pipeline, and the hollow fiber microfiltration membrane is connected to the filtrate cylinder pipeline for collecting the filtrate;

[0011] The ultrafiltration purification device comprises a circulation pump, a hollow fiber ultrafiltration membrane fixing frame, a magnetic plate, a magnetic bead container fixing clamp, and an electric pressure regulator. The hollow fiber ultrafiltration membrane fixing frame is used to fix the hollow fiber ultrafiltration membrane, the magnetic plate and the magnetic bead container fixing clamp are used to fix the low-adsorption magnetic bead container, the filtrate cylinder is connected to the circulation pump and the hollow fiber ultrafiltration membrane pipeline, the hollow fiber ultrafiltration membrane is connected to the electric pressure regulator pipeline, the hollow fiber ultrafiltration membrane and the electric pressure regulator are selectively connected to the low-adsorption magnetic bead container by a pipeline, and the electric pressure regulator is connected to the filtrate cylinder pipeline;

[0012] The suction device comprises a suction bucket bottom fixing groove, a suction bucket electric propeller and a suction bucket bottom fixing groove and an electric propulsion slide rail for fixing the suction bucket, and the suction bucket is connected with a filtrate cylinder and an ultrafiltration purification device pipeline.

[0013] Furthermore, the ultrafiltration purification devices are 1 to 3 groups connected in series or in parallel.

[0014] Furthermore, the hollow fiber microfiltration membrane includes a liquid inlet, a liquid outlet, a filtrate port Ι, and a filtrate port II, and the filtrate port Ι is connected to the filtrate cylinder; the hollow fiber ultrafiltration membrane includes a liquid inlet Ⅱ, a liquid outlet Ⅱ, a filtrate port III, and a filtrate port IV; the low-adsorption magnetic bead container includes a container cover, a container bin, a liquid inlet III, a liquid outlet III, the interior of the container bin is composed of a liquid separation partition, and the liquid outlet III is provided with a liquid outlet screen; the suction barrel includes a suction tube, a piston push-pull rod, and a liquid suction port.

[0015] Furthermore, in the ultrafiltration purification device, a main pipeline leading from the electric pressure regulator to the suction bucket and the filtrate cylinder is provided with a main pipeline electric liquid flow detection clamp, a loop pipeline between the ultrafiltration purification device and the filtrate cylinder is provided with a loop electric liquid flow detection clamp, and a suction path liquid flow detection clamp is provided on the pipeline between the ultrafiltration purification device and the suction bucket.

[0016] Furthermore, liquid level detectors are provided in the raw liquid tank and the filtrate tank.

[0017] Furthermore, the pipes used to connect the devices are silicone pipes.

[0018] In the present invention, the method for using the separation and purification device for stem cell exosomes and paracrine active macromolecules is specifically as follows:

[0019] The method for isolating and purifying stem cell exosomes is:

[0020] 1) Install and fix the separation and purification device of stem cell exosomes and paracrine active macromolecules, install and fix the stock liquid cylinder, filtrate cylinder, hollow fiber microfiltration membrane, hollow fiber ultrafiltration membrane, low adsorption magnetic bead container, and suction bucket, and connect the pipelines, place the stem cell exosome-rich culture fluid in the stock liquid cylinder, fix the buffer solution and eluent on the hooks, and use the electric clamps of the hanger pipeline to control the buffer solution and eluent to flow into the filtrate cylinder;

[0021] 2) Turn on the pretreatment pump, and the culture fluid rich in stem cell exosomes in the original liquid tank is filtered through the hollow fiber microfiltration membrane, and the filtrate is collected in the filtrate tank;

[0022] 3) After the pretreatment of step 2) is completed, the circulation pump is turned on and the pressure of the pressure regulator is adjusted so that the liquid in the filtrate cylinder is subjected to ultrafiltration and affinity adsorption in sequence through the hollow fiber ultrafiltration membrane and the low-adsorption magnetic bead container. The treated filtrate enters the filtrate cylinder and circulates for ultrafiltration and affinity adsorption. By controlling the electric clamp of the rack pipeline corresponding to the buffer solution, the buffer solution is added to the filtrate cylinder during the ultrafiltration and affinity adsorption process;

[0023] 4) Step 3) After the ultrafiltration and affinity adsorption treatment is completed, turn off the circulation pump, open the electric clamp of the rack pipeline corresponding to the eluent, add the eluent to the filtrate cylinder, close the electric clamp of the rack pipeline, turn on the circulation pump for elution, and elute the exosomes adsorbed on the magnetic beads. After the elution is completed, turn off the circulation pump;

[0024] 5) After elution is completed, the electric propeller is turned on to suck the liquid in the filtrate cylinder and the pipeline system into the suction bucket to complete the separation and purification of exosomes;

[0025] The method for isolating and purifying paracrine active macromolecules is:

[0026] 1) Install and fix the separation and purification device for stem cell exosomes and paracrine active macromolecules, install and fix the stock liquid cylinder, filtrate cylinder, hollow fiber microfiltration membrane, hollow fiber ultrafiltration membrane and suction bucket, place the culture fluid rich in paracrine active macromolecules in the stock liquid cylinder, fix the buffer on the hook, and use the electric clamp of the hanger pipeline to control the buffer to flow into the filtrate cylinder;

[0027] 2) The pretreatment pump is turned on, and the culture fluid rich in paracrine active macromolecules in the original liquid tank is filtered through the hollow fiber microfiltration membrane, and the filtrate is collected in the filtrate tank;

[0028] 3) After the pretreatment of step 2) is completed, the circulation pump is turned on and the pressure of the pressure regulator is adjusted to allow the liquid in the filtrate cylinder to be ultrafiltered through the hollow fiber ultrafiltration membrane. The treated filtrate enters the filtrate cylinder and circulates for ultrafiltration. By controlling the electric clamp of the rack pipeline corresponding to the buffer solution, the buffer solution is added to the filtrate cylinder during the ultrafiltration process;

[0029] 4) After ultrafiltration is completed, the electric propeller is turned on to suck the liquid in the filtrate cylinder and the pipeline system into the suction bucket to complete the separation and purification of paracrine active macromolecules.

[0030] Furthermore, the magnetic beads in the low-adsorption magnetic bead container are streptavidin affinity magnetic beads, and are cross-linked with biotin-labeled Tim4 antibodies.

[0031] In the present invention, the culture fluid rich in paracrine active macromolecules and the culture fluid rich in paracrine active macromolecules are obtained by a continuous production method, and a hollow fiber membrane bioreactor is used to culture cells in 3D. On the one hand, the culture space of the cells is closer to the three-dimensional microenvironment in the organism, and the secreted exosomes and active macromolecules are closer to their physiological activity in the organism; on the other hand, the cell culture space and the culture medium are divided by an ultrafiltration membrane, which can effectively isolate the exosomes secreted by the cells and the exosomes brought by the culture medium, so that there is no need to limit the use of a culture medium that removes exosomes; and the biological macromolecules in the culture medium or the biological macromolecules secreted by the cells can pass through the ultrafiltration membrane; the continuous production method, staged culture, enrichment of different products, staged harvesting of culture fluid, exosome production during the vigorous cell growth period, effectively ensuring the normal physiological function of exosomes, and 3D culture, cells grow in stacks, the cell expansion period is much higher than 2D culture, and paracrine biologically active macromolecules are produced when the cell number reaches saturation, effectively increasing the yield of active macromolecules.

[0032] The method for continuous production of stem cell exosomes and paracrine active macromolecules of the present invention specifically comprises the following steps:

[0033] (1) Hollow fiber membrane bioreactor 3D culture: Resuspend the in vitro subcultured stem cells in complete culture medium and inoculate them into the external space of the hollow fiber membrane bioreactor. Connect the complete culture medium tank and start the circulation pump. When the glucose consumption is greater than 80%, replace the culture medium.

[0034] (2) When the medium consumption rate tends to be stable, the stem cell exosome-rich culture medium is harvested from the hollow fiber external space, and the hollow fiber external space is filled with new complete culture medium. This step is repeated until the medium consumption rate begins to decrease significantly and the cell density of the hollow fiber external space is saturated;

[0035] (3) Replace the basic culture medium without biological macromolecules for cultivation, collect the culture medium rich in stem cell paracrine active macromolecules from the storage tank every once in a while, and replace the new basic culture medium with the same amount, and repeat this step 2 to 3 times;

[0036] (4) Extracting, separating and purifying the stem cell exosome culture medium and stem cell paracrine active macromolecule culture medium obtained in step (2) and step (3), respectively, to obtain stem cell exosomes and stem cell paracrine active macromolecules.

[0037] The above step (2) and the obtained stem cell exosome culture fluid are subjected to low temperature and centrifugal separation treatment, and the supernatant obtained after removing cell debris and protein precipitation is set aside; the stem cell paracrine active macromolecule culture fluid obtained in step (3) is centrifuged to remove cell debris to obtain a supernatant, which is set aside. The above complete culture medium is a serum-free basal medium for mesenchymal stem cells + 5% serum replacement. When the complete culture medium is used for culture, the culture conditions are 37°C and 5% CO2; the basal culture medium composition is DMEM / F12 + 1.5% D-glucose + 50μmol / L L-ascorbic acid. When the basal culture medium is used for culture, the culture conditions are 37°C, 5% CO2, 5% O2; in step (2), the volume of the complete culture medium replaced each time gradually increases according to the glucose consumption rate.

[0038] The present invention adopts a hollow fiber ultrafiltration membrane (ultrafiltration) and low-adsorption magnetic beads (affinity adsorption) to extract exosomes simultaneously. In the early stage of separation, the volume of the separation liquid can be rapidly reduced, and the concentration of exosomes is continuously increased, thereby making the adsorption of exosomes by affinity adsorption magnetic beads more and more efficient. The exosomes are adsorbed on the surface of the magnetic beads, which effectively reduces the content of free exosomes in the separation liquid, thereby greatly reducing the "extrusion effect" of the ultrafiltration process, thereby effectively avoiding ultrafiltration membrane blockage and exosome loss; and overcomes the shortcomings of the ultrafiltration method of slower and slower separation speed and product loss, while overcoming the shortcomings of the affinity adsorption magnetic bead method of being unable to process large-volume samples and being expensive, and has been significantly improved in extraction speed and recovery rate.

[0039] The present invention can significantly reduce the cost of consumables. The hollow fiber ultrafiltration membrane used in the device of the present invention can be reused more than ten times through a simple automated flushing process without replacement or backwashing, and the affinity magnetic beads can be reused more than five times without repeated filling.

[0040] The present invention uses the separation and purification device for stem cell exosomes and paracrine active macromolecules as an automated device, integrating functions such as hollow fiber membrane microfiltration, hollow fiber membrane ultrafiltration, magnetic bead affinity adsorption, product cleaning, product elution, and automatic product suction, so as to realize the automated extraction of exosomes and stem cell paracrine active macromolecules. It has a modular design and can independently increase the number of separation stages or combination methods, which greatly reduces the manual operation steps and improves the stability of product quality.

[0041] When extracting stem cell exosomes in the present invention, low speed and high pressure are used to effectively prevent the exosomes or cross-linked antibodies adsorbed on the surface of the magnetic beads from being washed away by the liquid flow. The liquid separation partition design in the magnetic bead container can effectively ensure the uniformity of the liquid when it flows over the surface of the magnetic beads, thereby maximizing the magnetic bead adsorption efficiency.

[0042] Beneficial Effects

[0043] The present invention organically combines tangential flow microfiltration, tangential flow ultrafiltration and magnetic bead adsorption into a separation system to separate and purify exosomes and active macromolecules in cell culture fluid, realizing an extraction strategy based on multiple principles simultaneously, overcoming the shortcomings of a single method, while further strengthening the advantages of a single method, greatly improving the purity and extraction efficiency of the product. BRIEF DESCRIPTION OF THE DRAWINGS

[0044] Figure 1 This is a schematic diagram of the overall structure of the separation and purification device for stem cell exosomes and paracrine active macromolecules;

[0045] Figure 2 Schematic diagram of hollow fiber microfiltration membrane;

[0046] Figure 3 Schematic diagram of hollow fiber ultrafiltration membrane;

[0047] Figure 4 The front view, side view and side cross-sectional view of the container of low-adsorption magnetic beads;

[0048] Figure 5 It is a schematic diagram of the suction barrel structure;

[0049] Figure 6 This is a schematic diagram of the pipeline system for separating and purifying stem cell exosomes in Example 2;

[0050] Figure 7 Flow chart for isolating and purifying stem cell exosomes;

[0051] Figure 8 This is a schematic diagram of the pipeline system for separating and purifying stem cell paracrine active macromolecules in Example 3;

[0052] Fig. 9 Flow chart for isolating and purifying active macromolecules secreted by stem cells;

[0053] Fig.10 This is a schematic diagram of the pipeline system for separating and purifying stem cell exosomes in Example 4;

[0054] Fig.11 This is a schematic diagram of the pipeline system for separating and purifying stem cell exosomes in Example 5;

[0055] Among them, 1 is a touch operation screen, 2 is a filter fixing rack, 3 is a pretreatment pump, 4 is a circulation pump, 5 is a hollow fiber ultrafiltration membrane fixing rack, 6 is a magnetic plate, 7 is a magnetic bead container fixing clip, 8 is an electric pressure regulator, 9 is a main pipeline electric liquid flow detection clip, 10 is a loop electric liquid flow detection clip, 11 is a product suction path liquid flow detection clip, 12 is a fixing groove for the lower edge of the suction bucket, 13 is a product suction bucket electric propeller, 13.1 is a fixing groove for the upper edge of the product suction bucket, 13.2 is an electric propulsion slide rail, 14 is a base of the stock solution cylinder, 15 is a base of the filtrate cylinder, 16 is a crossbar of the hanging rack, 16.1 is a hook, 17 is a vertical column of the hanging rack, 18 is a crossbar of the hanging rack pipeline electric clip, 18.1 is a hanging rack pipeline electric clip, 19 is a base of the hanging rack, 20 is a hollow fiber microfiltration membrane, 20.1 is the second liquid inlet, 20.2 is the first liquid outlet, 20.3 is the first filtrate outlet, 20.4 is the second filtrate outlet. 21 is a hollow fiber ultrafiltration membrane, 21.1 is the second liquid inlet, 21.2 is the second liquid outlet, 21.3 is the third filtrate outlet, 21.4 is the fourth filtrate outlet, 22 is a low adsorption magnetic bead container, 22.1 is a container cover, 22.2 is a container bin, 22.3 is the third liquid inlet, 22.4 is the third liquid outlet, 22.5 is a liquid separation partition board, 22.6 is a liquid outlet sieve mesh, 23 is a suction bucket, 23.1 is a suction pipe, 23.2 is a piston push rod, 23.3 is a liquid suction port. Detailed implementation mode

[0056] The following is described in conjunction with specific embodiments. The embodiments shown in the drawings of the present invention are only representative cases of the present invention, not all embodiments. Various changes and improvements can be made based on the present invention, and these changes and improvements all fall within the scope of protection of the present invention. Therefore, based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work fall within the scope of protection of the present invention.

[0057] The overall structural schematic diagram of the device for separating and purifying stem cell exosomes and paracrine active macromolecules in the present invention is as Figure 1 shown, including a main control panel device, a liquid storage device and a liquid storage hanging rack;

[0058] The main control panel device includes a touch operation screen 1, a pretreatment device, an ultrafiltration purification device and a suction device. The liquid storage device includes a base 14 of the stock solution cylinder and a base 15 of the filtrate cylinder, which are used to fix the stock solution cylinder and the filtrate cylinder, and a liquid level detector is arranged in the stock solution cylinder and the filtrate cylinder; the liquid storage hanging rack is in the shape of a "king", and the crossbars from top to bottom are respectively a crossbar 16 of the hanging rack, a crossbar 18 of the hanging rack pipeline electric clip and a base 19 of the hanging rack, and the vertical rod is a vertical column 17 of the hanging rack. Six hooks 16.1 are installed on the crossbar 16 of the hanging rack to fix the buffer solution and the eluent. Six hanging rack pipeline electric clips 18.1 are installed on the crossbar 18 of the hanging rack pipeline electric clip to control the buffer solution and the eluent to flow into the filtrate cylinder; the ultrafiltration purification device has 3 groups and is connected in series or parallel through pipelines during use;

[0059] The pretreatment device is composed of a filter fixing frame 2 and a pretreatment pump 3. The filter fixing frame 2 is used to fix the hollow fiber microfiltration membrane 20. The raw liquid cylinder is connected to the liquid inlet 1 20.1 of the hollow fiber microfiltration membrane 20 through the pretreatment pump 3. The liquid outlet 1 20.2 of the hollow fiber microfiltration membrane 20 is connected to the raw liquid cylinder. The filtrate port 1 20.3 of the hollow fiber microfiltration membrane 20 is connected to the filtrate cylinder pipeline.

[0060] The ultrafiltration adsorption device is composed of a circulation pump 4, a hollow fiber ultrafiltration membrane fixing frame 5, a magnetic plate 6, a magnetic bead container fixing clamp 7 and an electric pressure regulator 8. The hollow fiber ultrafiltration membrane fixing frame 5 is used to fix the hollow fiber ultrafiltration membrane 21, the magnetic plate 6 and the magnetic bead container fixing clamp 7 are used to fix the low-adsorption magnetic bead container 22, the filtrate cylinder is connected to the hollow fiber ultrafiltration membrane 21 through a pipeline through the circulation pump 4, the hollow fiber ultrafiltration membrane 21 is connected to the electric pressure regulator 8 through a pipeline, and the low-adsorption magnetic bead container 22 is selectively connected between the hollow fiber ultrafiltration membrane 21 and the electric pressure regulator 8. In the ultrafiltration purification device, the main pipeline leading from the electric pressure regulator 8 to the suction bucket 23 and the filtrate cylinder is provided with a main line electric liquid flow detection clamp 9, the loop pipeline between the ultrafiltration purification device and the filtrate cylinder is provided with a loop electric liquid flow detection clamp 10, and the pipeline between the ultrafiltration purification device and the suction bucket 23 is provided with a suction line liquid flow detection clamp 11;

[0061] The suction device is composed of a suction bucket bottom edge fixing groove 12, a suction bucket electric propeller 13, a suction bucket bottom edge fixing groove 13.1 and an electric propulsion slide rail 13.2, which is used to fix the suction bucket 23. The suction bucket 23 is connected to the filtrate cylinder and the separation and purification device through a pipeline; a suction path liquid flow detection clamp 11 is provided on the pipeline between the ultrafiltration purification device and the suction bucket 23.

[0062] The schematic diagrams of the hollow fiber microfiltration membrane 20 and the hollow fiber ultrafiltration membrane 21 described in the present invention are shown in FIG. Figure 2 and Figure 3 As shown, the hollow fiber microfiltration membrane 20 includes a liquid inlet 1 20.1, a liquid outlet 1 20.2, a filtrate port 1 20.3, and a filtrate port II 20.4, the liquid inlet 120.1 is connected to the pretreatment pump 3 through a pipeline, the liquid outlet 120.2 is connected to the raw liquid tank through a pipeline, and the filtrate port 120.3 is connected to the filtrate tank; the hollow fiber ultrafiltration membrane 21 includes a liquid inlet 1 21.1, a liquid outlet 121.2, a filtrate port Ш21.3, and a filtrate port IV 21.4, the liquid inlet 1 21.1 is connected to the circulation pump 4 through a pipeline, the liquid outlet 121.2 is selectively connected to the low-adsorption magnetic bead container 22 or the electric pressure regulator 8 through a pipeline, and the filtrate port Ш 21.3 is connected to the waste liquid tank through a pipeline.

[0063] The front view and side cross-sectional view of the low adsorption magnetic bead container 22 described in the present invention are as follows: Figure 4 As shown, the low-adsorption magnetic bead container 23 includes a container cover 22.1, a container compartment 22.3, a liquid inlet Ш 22.3, and a liquid outlet Ш 22.4. The container compartment 22.3 is pointed bottomed to facilitate the absorption of the magnetic beads. A liquid separation partition 22.5 is provided inside the container compartment 22.3, and a liquid outlet screen 22.6 is provided at the position of the liquid outlet Ш 22.4 to prevent the magnetic beads from being washed out. The liquid inlet Ш 22.3 is selectively connected to the hollow fiber microfiltration membrane 20 through a pipeline, and the liquid outlet Ш 22.4 is selectively connected to the electric pressure regulator 8 through a pipeline.

[0064] The schematic diagram of the structure of the suction bucket 23 described in the present invention is as follows Figure 5 As shown, it includes a suction pipe 23.1, a piston push-pull rod 23.2, a liquid suction port 23.3, 23.4 is the lower edge of the suction barrel, 23.5 is the upper edge of the suction barrel, and the liquid suction port 23.3 is connected to the filtrate cylinder and the separation and purification device through a pipeline.

[0065] The connecting pipes mentioned above in the present invention are all silicone pipes.

[0066] In conjunction with the accompanying drawings and specific embodiments, the method for using the separation and purification device for stem cell exosomes and paracrine active macromolecules in the present invention is described.

[0067] Example 1

[0068] The composition of the complete culture medium is: serum-free basal medium for mesenchymal stem cells + 5% serum replacement;

[0069] The composition of the basal medium was: DMEM / F12 + 1.5% D-glucose + 50 μmol / L L-ascorbic acid;

[0070] Hollow fiber membrane bioreactor specifications: molecular weight cut-off 100kD (95% cut-off rate), membrane surface area 1.2m 2 , the volume of the hollow fiber external space is 70 mL; the hollow fiber membrane bioreactor is pretreated with PBS and culture medium according to the instructions;

[0071] (1) 2D culture of seed cells: Take fresh umbilical cord and separate Wharton's jelly under sterile environment, suspend tissue blocks in complete culture medium and spread them in bottles. Observe cell growth under an inverted microscope. When cells grow to 80% healed, digestion and passage should be performed. Cell density is 1×10 4 / cm 2 Re-plate the flask and change the medium every 3 days. When the cells grow to 80% confluent, repeat the above subculture process. The incubator conditions are 37°C and 5% CO2.

[0072] (2) Hollow fiber membrane bioreactor 3D culture: Take 5*10 P3 cells 8, resuspended with serum-free complete medium, inoculated into the outer space of the hollow fiber membrane bioreactor, the inner space of the hollow fiber is connected to the complete medium storage tank, the initial medium volume is 250mL, the circulation pump is turned on, the pump speed is set to medium speed, the device is placed in a 37°C, 5% CO2 incubator for culture, samples are taken from the medium storage tank every 12 hours, and the glucose content is measured with a glucose meter. When 80% of the glucose is consumed, the new medium is replaced. According to the glucose consumption rate, the volume of the new medium replaced each time should be gradually increased. The medium is changed every 2 days in the first 10 days, and then it is changed once a day;

[0073] (3) After culturing in the hollow fiber membrane bioreactor for 10 days, the medium consumption rate tended to be stable, and the culture medium rich in exosomes was harvested from the hollow fiber external space every day, about 70 mL each time, and the hollow fiber external space was filled with new complete culture medium. Around the 40th day, the medium consumption rate began to decrease significantly, and the cell density in the hollow fiber external space was saturated. The culture medium was collected for the last time to obtain the stem cell exosome-rich culture medium, and the hollow fiber external space was filled with new complete culture medium; the obtained stem cell exosome-rich culture medium was separated by low temperature (4°C, 24h) and centrifugation (1200g, centrifugation for 10min), and the supernatant obtained after removing cell debris and protein precipitate was set aside;

[0074] (4) Harvesting of stem cell paracrine macromolecules: Replace the culture medium in the culture medium tank with a basic culture medium without biological macromolecules for cultivation; transfer the device to a three-gas incubator and adjust the culture parameters to 37°C, 5% CO2, and 5% O2; collect all the old culture medium from the culture medium tank every 24 hours to extract stem cell paracrine bioactive macromolecules, and replace with new basic culture medium in equal amounts; repeat the harvesting steps at 48 hours and 72 hours; terminate the cell culture process after 72 hours to obtain a culture medium rich in stem cell paracrine macromolecules. The obtained stem cell paracrine macromolecule culture medium is centrifuged (1200g, 10 minutes) to remove cell debris to obtain the supernatant for standby use.

[0075] Example 2

[0076] The schematic diagram of the pipeline system for separating and purifying stem cell exosomes in Example 2 is as follows Figure 6 The flow chart for isolating and purifying stem cell exosomes is shown in Figure 7 As shown, the processing volume of each batch is 150mL;

[0077] The specific method for isolating and purifying stem cell exosomes is as follows:

[0078] 1) Install and fix the separation and purification device for stem cell exosomes and paracrine active macromolecules, install and fix the raw liquid tank, filtrate tank, hollow fiber microfiltration membrane 20 (pore size of 0.22μm), hollow fiber ultrafiltration membrane 21 (molecular weight cutoff of 100kD), low adsorption magnetic bead container 22 (filled with commercial streptavidin affinity magnetic beads, cross-linked biotin labeled Tim4 antibody) and suction bucket 23, and press Figure 6 The connecting pipeline shown, wherein a low-adsorption magnetic bead container 22 is connected between the hollow fiber ultrafiltration membrane 21 and the electric pressure regulator 8, the stem cell exosome-rich culture fluid is placed in the original fluid cylinder, the buffer solution and the eluent are respectively fixed on the hooks 16.1 installed on the rack crossbar 16, and the rack pipeline electric clamps 18.1 are used to control the flow of the buffer solution and the eluent;

[0079] 2) Turn on the pretreatment pump 3, set the pump speed to medium speed, filter the stem cell exosome-rich culture fluid in the stock liquid tank through the hollow fiber microfiltration membrane 20, and collect all the filtrate into the filtrate tank. After the culture fluid in the stock liquid tank is exhausted, turn off the pretreatment pump 3 and proceed to the next step;

[0080] 3) Automatically start the circulation pump 4, set the pump speed to low speed, adjust the pressure regulator 8 to high pressure, and circulate and filter until the volume of the filtrate is 1 / 10 of the original volume, then pause the circulation pump 4, open the rack pipeline electric clamp 18.1 corresponding to the buffer solution, and the buffer solution flows into the filtrate cylinder. When the volume of the filtrate in the filtrate cylinder reaches 150 mL, automatically close the rack pipeline electric clamp 18.1, start the circulation pump 4, continue to circulate and filter until the volume of the filtrate is 1 / 50 of the original volume of the culture solution, then pause the circulation pump 4, open the rack pipeline electric clamp 18.1 corresponding to the buffer solution, and the buffer solution flows into the filtrate cylinder. When the volume of the filtrate in the filtrate cylinder reaches 150 mL, automatically close the rack pipeline electric clamp 18.1, start the circulation pump 4, continue to circulate and filter until the volume of the filtrate is 1 / 50 of the original volume of the culture solution, then pause the circulation pump 4, and proceed to the next step;

[0081] 4) Step 3) After the ultrafiltration and affinity adsorption are completed, the electric clamp 18.1 of the rack pipeline corresponding to the eluent is opened, and the eluent flows into the filtrate cylinder. When the liquid volume in the filtrate cylinder increases to 1 / 10, the electric clamp 18.1 of the rack pipeline corresponding to the eluent is automatically closed, the circulation pump 4 is turned on, the pressure regulator 8 is fully opened, and the circulation elution is performed for 60 seconds. After the elution is completed, the circulation pump 4 is turned off and the next step is entered;

[0082] 5) The electric propeller 13 is turned on to suck the liquid in the filtrate cylinder and the pipeline system into the suction bucket 23, completing the separation and purification of exosomes; when liquid continuously flows through the main pipeline electric liquid flow detection clamp 9, the loop electric liquid flow detection clamp 10, and the suction pipeline liquid flow detection clamp 11 at the same time, the clamping function is activated and turned on; when it is detected that there is no liquid flowing through the pipeline, the clamp automatically clamps, and when all three clamps are clamped, the suction automatically stops, and the stem cell exosome separation and purification process is completed, and stem cell exosomes are obtained in the suction bucket 23;

[0083] 6) According to the subsequent product use, if the eluent needs to be replaced, the dialysis bag can be used for buffer replacement; if sterilization is required, it can be sterilized by filtering with a 0.22uM filter membrane;

[0084] 7) After completing a separation procedure, start the automatic cleaning program, flush the pipeline system with buffer, and then carry out the next batch of separation; the hollow fiber membrane can be reused without a significant decrease in separation speed, and the immunoaffinity magnetic beads can be reused 5 times.

[0085] Example 3

[0086] The schematic diagram of the pipeline system for separating and purifying stem cell paracrine active macromolecules in Example 2 is as follows: Figure 8 The flow chart for isolating and purifying stem cell exosomes is shown in Fig. 9 As shown, the processing volume of each batch is 150mL;

[0087] The specific method for isolating and purifying stem cell paracrine active macromolecules is as follows:

[0088] 1) Install and fix the separation and purification device for stem cell exosomes and paracrine active macromolecules, install and fix the raw liquid tank, filtrate tank, hollow fiber microfiltration membrane 20 (pore size of 0.1μm), hollow fiber ultrafiltration membrane 21 (throttling molecular weight of 5kD) and suction bucket 23, and press Figure 8 The connecting pipeline shown in the figure, wherein the hollow fiber ultrafiltration membrane 21 is connected to the electric pressure regulator 8, the culture solution rich in stem cell paracrine active macromolecules is placed in the original liquid tank, the buffer solution is fixed on the hook 16.1 installed on the rack crossbar 16, and the rack pipeline electric clamp 18.1 is used to control the inflow of the buffer solution;

[0089] 2) Start the pretreatment pump 3, set the pump speed to medium speed, filter the culture fluid rich in stem cell paracrine active macromolecules in the stock liquid tank through the hollow fiber microfiltration membrane 20, and collect all the filtrate into the filtrate tank. After the culture fluid in the stock liquid tank is exhausted, turn off the pretreatment pump 3 and proceed to the next step;

[0090] 3) Automatically start the circulation pump 4, set the pump speed to low speed, adjust the pressure regulator 8 to high pressure, and circulate and filter until the filtrate volume is 1 / 10 of the original, then pause the circulation pump 4, open the rack pipeline electric clamp 18.1 corresponding to the buffer solution, and the buffer solution flows into the filtrate cylinder. When the filtrate volume in the filtrate cylinder reaches 150 mL, automatically close the rack pipeline electric clamp 18.1, start the circulation pump 4, and continue to circulate and filter until the filtrate volume is 1 / 50 of the original culture solution volume, then pause the circulation pump 4, open the rack pipeline electric clamp 18.1 corresponding to the buffer solution, and the buffer solution flows into the filtrate cylinder. When the filtrate volume in the filtrate cylinder reaches 150 mL, automatically close the rack pipeline electric clamp 18.1, start the circulation pump 4, and continue to circulate until the filtrate volume is 1 / 50 of the original culture solution volume, then pause the circulation pump 4 and proceed to the next step;

[0091] 4) The electric propeller 13 is turned on to suck the liquid in the filtrate cylinder and the pipeline system into the suction bucket 23 to complete the separation and purification of paracrine active macromolecules; when liquid continuously flows through the main pipeline electric liquid flow detection clamp 9, the loop electric liquid flow detection clamp 10, and the suction pipeline liquid flow detection clamp 11 at the same time, the clamping function is activated and turned on; when it is detected that there is no liquid flowing through the pipeline, the clamp automatically clamps, and when all three clamps are clamped, the suction automatically stops, and the stem cell exosome separation and purification process is completed, and the stem cell exosome product is obtained in the suction bucket 23;

[0092] 5) Depending on the subsequent product use, if sterilization is required, it can be sterilized by filtering with a 0.22uM filter membrane;

[0093] 6) After completing a separation process, start the automatic cleaning program, flush the pipeline system with buffer solution, and then proceed to the next batch of separation; the central control fiber membrane can be reused if the separation speed does not decrease significantly.

[0094] Example 4

[0095] Example 4 Schematic diagram of the pipeline system for separating and purifying stem cell exosomes Fig.10 As shown, three sets of ultrafiltration purification devices are connected in series; the rest of the operations are the same as in Example 1.

[0096] Example 5

[0097] Example 5 Schematic diagram of the pipeline system for separating and purifying stem cell exosomes Fig.11 As shown, three groups of ultrafiltration purification devices are connected in parallel; the rest of the operations are the same as in Example 1.

[0098] Comparative Example 1

[0099] according to Figure 8 The pipeline system was connected, and the stem cell exosomes were extracted by ultrafiltration. The other operations were the same as in Example 2.

[0100] Data analysis

[0101] The total protein content was detected by BCA method, the total number of particles (50-150nm) was detected by NanoSight nanoparticle analyzer, and the concentration of representative biomacromolecules (VEGF, GDNF, bFGF) was detected by ELISA method.

[0102] The total amount of protein, the total number of exosome particles, and the separation and purification time before and after the separation and purification of stem cell exosomes in Example 2, Examples 4-5, and Comparative Example 1 were detected and recorded. The results are shown in Table 1 below. As can be seen from Table 1, the separation speed of the separation and purification method of the present invention is significantly better than that of Comparative Example 1 (solid hollow fiber ultrafiltration membrane treatment), and the protein recovery rate and the recovery rate of exosome particles are also significantly better than those of Comparative Example 1.

[0103] The total protein content of the paracrine active macromolecules of stem cells and the concentration of representative biomacromolecules (VEGF, GDNF, bFGF) before and after separation and purification in Example 3 were detected. The results are shown in Table 2 below.

[0104] Table 1 Comparison of stem cell exosome isolation and purification results

[0105]

[0106] Table 2 Results of separation and purification of active macromolecules from stem cell exosomes

[0107] .

Claims

1. A separation and purification device for stem cell exosomes and paracrine active macromolecules, characterized in that: It includes a main control panel device, a liquid storage device, and a liquid storage hanger; The main control panel device includes a touch operation screen (1), a pretreatment device, an ultrafiltration purification device, and a suction device. The liquid storage device includes a stock solution cylinder base (14) and a filtrate cylinder base (15) for fixing the stock solution cylinder and the filtrate cylinder. The liquid storage hanger is in the shape of a "king", and the horizontal bars from top to bottom are the hanger cross bar (16), the hanger pipeline electric clamp cross bar (18), and the hanger base (19). The vertical bar is the hanger column (17). A number of hooks (16.1) are installed on the hanger cross bar (16) for fixing buffer solution and eluent. A number of hanger pipeline electric clamps (18.1) are installed on the hanger pipeline electric clamp cross bar (18) to control the inflow of buffer solution and eluent. The buffer solution and eluent are selectively connected to the filtrate cylinder pipeline; The pretreatment device includes a filter holder (2) and a pretreatment pump (3). The filter holder (2) is used to fix the hollow fiber microfiltration membrane (20). The stock solution cylinder is connected to the pretreatment pump (3) and the hollow fiber microfiltration membrane (20) by pipelines. The hollow fiber microfiltration membrane (20) is connected to the stock solution cylinder by a pipeline, and the hollow fiber microfiltration membrane (20) is connected to the filtrate cylinder by a pipeline for collecting filtrate; The ultrafiltration purification device includes a circulation pump (4), a hollow fiber ultrafiltration membrane holder (5), a magnetic plate (6), a magnetic bead container fixing clip (7), and an electric pressure regulator (8). The hollow fiber ultrafiltration membrane holder (5) is used to fix the hollow fiber ultrafiltration membrane (21). The magnetic plate (6) and the magnetic bead container fixing clip (7) are used to fix the low adsorption magnetic bead container (22). The filtrate cylinder is connected to the circulation pump (4) and the hollow fiber ultrafiltration membrane (21) by pipelines. The hollow fiber ultrafiltration membrane (21) is connected to the electric pressure regulator (8) by a pipeline. The low adsorption magnetic bead container (22) is selectively connected by a pipeline between the hollow fiber ultrafiltration membrane (21) and the electric pressure regulator (8). The electric pressure regulator (8) is connected to the filtrate cylinder by a pipeline; The suction device includes a suction barrel lower edge fixing groove (12), a suction barrel electric pusher (13), a suction barrel upper edge fixing groove (13.1), and an electric pusher slide rail (13.2) for fixing the suction barrel (23). The suction barrel (23) is connected to the filtrate cylinder and the ultrafiltration purification device by pipelines; The hollow fiber microfiltration membrane (20) comprises a liquid inlet (20.1), a liquid outlet (20.2), a filtrate port I (20.3), and a filtrate port II (20.4), wherein the filtrate port I (20.3) is connected to a filtrate cylinder; the hollow fiber ultrafiltration membrane (21) comprises a liquid inlet II (21.1), a liquid outlet II (21.2), a filtrate port III (21.3), and a filtrate port IV (21.4); the low-adsorption magnetic bead container (22) comprises a container cover (22.1), a container bin (22.2), a liquid inlet III (22.3), and a liquid outlet III (22.4); the container bin (22.2) is provided with a liquid separation partition (22.5), and the liquid outlet III (22.4) is provided with a liquid outlet screen (22.6); the suction barrel (23) comprises a suction pipe (23.1), a piston push-pull rod (23.2), and a liquid suction port (23.3).

2. The separation and purification device for stem cell exosomes and paracrine active macromolecules according to claim 1, characterized in that: The ultrafiltration purification devices are 1 to 3 groups connected in series or in parallel.

3. The separation and purification device for stem cell exosomes and paracrine active macromolecules according to claim 1, characterized in that: In the ultrafiltration purification device, a main pipeline leading from the electric pressure regulator (8) to the suction bucket (23) and the filtrate cylinder is provided with a main pipeline electric liquid flow detection clamp (9), a loop pipeline between the ultrafiltration purification device and the filtrate cylinder is provided with a loop electric liquid flow detection clamp (10), and a suction pipeline liquid flow detection clamp (11) is provided on the pipeline between the ultrafiltration purification device and the suction bucket (23).

4. The separation and purification device for stem cell exosomes and paracrine active macromolecules according to claim 1, characterized in that: Liquid level detectors are arranged in the raw liquid cylinder and the filtrate cylinder.

5. The separation and purification device for stem cell exosomes and paracrine active macromolecules according to claim 1, characterized in that: The pipes used to connect the devices are silicone pipes.

6. A method for using the device for separating and purifying stem cell exosomes and paracrine active macromolecules according to any one of claims 1 to 5, characterized in that: The method for isolating and purifying stem cell exosomes is: 1) Install and fix a separation and purification device for stem cell exosomes and paracrine active macromolecules, install and fix a stock liquid tank, a filtrate tank, a hollow fiber microfiltration membrane (20), a hollow fiber ultrafiltration membrane (21), a low adsorption magnetic bead container (22), and a suction bucket (23), and connect the pipelines, place a stem cell exosome-rich culture fluid in the stock liquid tank, fix a buffer solution and an eluent on a hook (16.1), and use a rack pipeline electric clamp (18.1) to control the buffer solution and the eluent to flow into the filtrate tank; 2) starting the pretreatment pump (3), filtering the stem cell exosome-rich culture fluid in the original fluid tank through the hollow fiber microfiltration membrane (20), and collecting the filtrate into the filtrate tank; 3) After the pretreatment in step 2) is completed, the circulation pump (4) is turned on and the pressure of the electric pressure regulator (8) is adjusted so that the liquid in the filtrate cylinder is subjected to ultrafiltration and affinity adsorption in sequence through the hollow fiber ultrafiltration membrane (21) and the low-adsorption magnetic bead container (22). The treated filtrate enters the filtrate cylinder and circulates for ultrafiltration and affinity adsorption. By controlling the electric clamp (18.1) of the rack pipeline corresponding to the buffer solution, the buffer solution is added to the filtrate cylinder during the ultrafiltration and affinity adsorption process. 4) Step 3) After the ultrafiltration and affinity adsorption treatments are completed, the circulation pump (4) is turned off, the electric clamp (18.1) of the rack pipeline corresponding to the eluent is opened, the eluent is added to the filtrate tank, and the electric clamp (18.1) of the rack pipeline is closed, and the circulation pump (4) is turned on for elution to elute the exosomes adsorbed on the magnetic beads. After the elution is completed, the circulation pump (4) is turned off; 5) After the elution is completed, the electric propeller (13) of the suction bucket is turned on to suck the liquid in the filtrate cylinder and the pipeline system into the suction bucket (23), thereby completing the separation and purification of the exosomes; The method for isolating and purifying paracrine active macromolecules is: 1) Install and fix a separation and purification device for stem cell exosomes and paracrine active macromolecules, install and fix a stock liquid tank, a filtrate tank, a hollow fiber microfiltration membrane (20), a hollow fiber ultrafiltration membrane (21) and a suction bucket (23), place a culture solution rich in paracrine active macromolecules in the stock liquid tank, fix a buffer solution on a hook (16.1), and use a rack pipeline electric clamp (18.1) to control the buffer solution to flow into the filtrate tank; 2) starting the pretreatment pump (3), filtering the culture fluid rich in paracrine active macromolecules in the original liquid tank through the hollow fiber microfiltration membrane (20), and collecting the filtrate into the filtrate tank; 3) After the pretreatment in step 2) is completed, the circulation pump (4) is turned on and the pressure of the electric pressure regulator (8) is adjusted so that the liquid in the filtrate tank is ultrafiltered through the hollow fiber ultrafiltration membrane (21). The treated filtrate enters the filtrate tank and circulates for ultrafiltration. During the ultrafiltration process, the buffer is added to the filtrate tank by controlling the electric clamp (18.1) of the rack pipeline corresponding to the buffer; 4) After the ultrafiltration is completed, the electric propeller (13) of the suction bucket is turned on to suck the liquid in the filtrate cylinder and the pipeline system into the suction bucket (23), thereby completing the separation and purification of the paracrine active macromolecules.

7. The method of use according to claim 6, characterized in that: The magnetic beads in the low-adsorption magnetic bead container (22) are streptavidin affinity magnetic beads and are cross-linked with biotin-labeled Tim4 antibodies.